BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25539731)

  • 1. Hodgkin's lymphoma: better outcomes with fewer drugs?
    Casasnovas O; Coiffier B
    Lancet; 2015 Apr; 385(9976):1371-3. PubMed ID: 25539731
    [No Abstract]   [Full Text] [Related]  

  • 2. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
    Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
    Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
    Basaran G; Agaoglu F; Basaran M
    J Clin Oncol; 2010 Sep; 28(27):e485-6; author reply e487. PubMed ID: 20606082
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
    Johnson PW; Radford JA; Cullen MH; Sydes MR; Stenning SP; Hancock BW
    J Clin Oncol; 2006 Jul; 24(20):3309; author reply 3309-10. PubMed ID: 16829655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 6. Presentation of Hodgkin's lymphoma with Ophelia syndrome.
    Olmos D; Rueda A; Jurado JM; Alba E
    J Clin Oncol; 2007 May; 25(13):1802-3. PubMed ID: 17470872
    [No Abstract]   [Full Text] [Related]  

  • 7. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary cutaneous Hodgkin's lymphoma.
    Mukesh M; Shuttleworth D; Murray P
    Clin Exp Dermatol; 2009 Dec; 34(8):e673-5. PubMed ID: 19817768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stanford V and radiotherapy for Hodgkin's disease.
    Portlock CS
    Curr Oncol Rep; 2002 Sep; 4(5):413. PubMed ID: 12162915
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rescue treatment in Hodgkin's disease].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 12. Unusual presentation of Hodgkin's lymphoma.
    Knibbeler-van Rossum CT; Peters FJ; Erdkamp FL; Bos LP
    Ann Oncol; 2002 Apr; 13(4):637-8. PubMed ID: 12056718
    [No Abstract]   [Full Text] [Related]  

  • 13. Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation.
    Simpson L; Taylor S; Piotrowski A
    J Clin Oncol; 2004 Jan; 22(1):196-8. PubMed ID: 14701784
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiotherapy and Hodgkin's lymphoma.
    Das P; Ha CS; Cox JD
    J Clin Oncol; 2005 Dec; 23(34):8914; author reply 8914-6. PubMed ID: 16314655
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors in early-stage Hodgkin's disease.
    Sarris AH
    J Clin Oncol; 1997 Jan; 15(1):411-2. PubMed ID: 8996173
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma].
    Torrent A; Navarro JT; Andreo FC; Ribera JM
    Med Clin (Barc); 2013 Aug; 141(3):134-5. PubMed ID: 23332624
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
    Xicoy B; Miralles P; Morgades M; Rubio R; Valencia ME; Ribera JM
    Haematologica; 2013 Aug; 98(8):e85-6. PubMed ID: 23716563
    [No Abstract]   [Full Text] [Related]  

  • 18. Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor.
    Gastaldi R; Martino P; Gentile G; Picardi V; De Propris MS; Pirillo MF; De Vellis A; Mandelli F
    Ann Oncol; 2002 Jul; 13(7):1158-60. PubMed ID: 12176798
    [No Abstract]   [Full Text] [Related]  

  • 19. Pericardial effusion due to pericardium involvement by Hodgkin's lymphoma.
    Guastafierro S; Cappabianca S; Falcone U
    Ann Hematol; 2013 Jun; 92(6):853-4. PubMed ID: 23196418
    [No Abstract]   [Full Text] [Related]  

  • 20. Mees' lines because of chemotherapy for Hodgkin's lymphoma.
    Piccolo V; Corneli P; Zalaudek I; Argenziano G; Conforti C; Alfano R; Russo T
    Int J Dermatol; 2020 Feb; 59(2):e38. PubMed ID: 31566709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.